HMC Appoints Medical Director of Communicable Disease Center

Doha, Hamad Medical Corporation (HMC) announced the appointment of Dr. Muna Al Maslamani to the role of Medical Director of the Communicable Disease Center (CDC), which is a new dedicated facility for the identification and treatment of infectious diseases in Qatar, inaugurated in November 2016.

Commenting on the appointment, Chief Medical Officer at HMC Professor Michael Richmond said that Dr. Al Maslamani is a great asset to both HMC and the CDC. “As well as being a highly skilled senior consultant in infectious diseases, Dr. Al Maslamani has extensive experience in quality improvement. Her clinical leadership roles have included Deputy Chair and Acting Chair of Medicine and Assistant Head of Infectious Disease. She is eminently suited to lead this new and important facility,” he said.

HMC’s Deputy Chief Medical Officer and Head of Infectious Diseases, Dr. Abdullatif Al Khal, said: “She is a wonderful example of the realization of our strategy to develop leadership capabilities among our Qatari clinicians. She will be an excellent role model for the next generation of doctors who will lead our healthcare system in the future.” The CDC is a state-of-the-art facility for people with infectious diseases. It offers comprehensive inpatient services to those who need hospitalization and also houses outpatient clinics which provide services including pre-marital counselling and education for individuals with infectious diseases. The Center has a focus on tuberculosis (TB), respiratory diseases and other infectious diseases, including leprosy, Middle East respiratory syndrome (MERS), influenza, measles, hepatitis and human immunodeficiency virus (HIV).

Source: Qatar News Agency